Anterix Inc.ATEX
Key ratios
EPS growth
118.8%TTM
FCF / Sales
151.0%TTM
2026
84.3%2025
-486.6%2024
994.7%
Net margin
933.0%TTM
2026
1394.2%2025
-188.6%2024
-217.8%
ROA
-6.5%2026
2025
-9.3%2024
-10.9%
ROE
43.3%2026
2025
-7.2%2024
-5.4%
Revenue growth
18.9%TTM
2026
7.8%2025
43.9%2024
118.4%
Recent news
Anterix Inc. Reports First Quarter Fiscal Year 2027 Results
Anterix Issues Statement in Support of SpaceX Proposal
Track ATEX in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer